Saturday links: the case against complaining
Tadas Viskanta
Abnormal Returns
13 hours ago
4 MIN READ
Autos
- Nobody wants Cybertrucks. (sherwood.news)
- A profile of Lyft ($LYFT) CEO David Risher. (semafor.com)
- How fast will the autonomous car market grow? (sherwood.news)
- A woman recently give birth in a Waymo on the way to the hospital. (nbcnews.com)
Energy
- Why BP and Shell failed to transform their businesses. (ft.com)
- How solar is getting rolled out across Africa. (climatedrift.substack.com)
Environment
- Why Tehran is running out of water. (wired.com)
- How the deep ocean’s carbon-fixing engine works. (sciencedaily.com)
Animals
- How humans rank among mammalian monogomy. (wsj.com)
- The fact that human sperm ever fertilizes an egg is kind of miracle. (knowablemagazine.org)
- We keep discovering new deep sea species. (oceancensus.org)
- Repelling fish is harder than it seems. (wsj.com)
Science
- Immigrants are over-represented among American Nobel Prize science winners. (nytimes.com)
- A Q&A with Stuart Buck who is the executive director of the Good Science Project. (fasterplease.substack.com)
Technology
Behavior
- AI chatbots weren’t designed to be therapists. (ft.com)
- The FDA approved Flow Neuroscience’s at-home brain stimulation device to treat depression. (reuters.com)
- How to build up some emotional resilience. (experimentalliving.substack.com)
- Five insights from Robert Coplan’s new book, “The Joy of Solitude: How to Reconnect with Yourself in an Overconnected World.” (nextbigideaclub.com)
- Gender essentialism is making a big comeback. (theargumentmag.com)
- What is “wounded striving”? (forbes.com)
Vaccines
- On the safety of Covid mRNA vaccines. (jamanetwork.com)
- Covid vaccines cut ER visits for children. (scientificamerican.com)
- South Carolina is a measles hot spot. (semafor.com)
Health
- The FDA approved the first gonorrhea drug in decades. (medpagetoday.com)
- Is the surge in cancer diagnoses due to more imaging? (nytimes.com)
- More research showing the dangers of forever chemicals. (msn.com)
- How Slovenia has tackled chronic disease. (statnews.com)
Weed
- Suicide rates among older Americans have fallen after recreational marijuana legalization. (papers.ssrn.com)
- Research on the medical benefits of cannabis use is ‘often weak or inconclusive.’ (sciencedaily.com)
Fitness
- Get some sun early in the morning. (twopct.com)
- There is a tradeoff between muscle strength and aerobic capacity. (peterattiamd.com)
- Why you need to prioritize sleep. (newatlas.com)
Dogs
- Your dog’s genetics won’t tell you much about their behavior. (arstechnica.com)
- Five insights from “The Science of Pets” by Jay Ingram. (nextbigideaclub.com)
Drink
- Canadian consumers continue to shun American liquors. (fooddive.com)
- Thrive Market is he first major online grocer to eliminate alcohol entirely from its marketplace. (cnbc.com)
Food
- Steakhouses are scrambling to cover higher beef prices. (msn.com)
- Pickles are everywhere these days. (businessinsider.com)
- China loves Chilean cherries. (financialpost.com)
Sports
- Don’t expect a flood of direct private equity investment into athletic programs. (frontofficesports.com)
- International soccer corruption case dropped by DOJ. (pbs.org)
- Schedule changes are coming to college soccer. (sportico.com)
Entertainment
- ‘Zootopia 2’ is a big hit. (variety.com)
- Richard Brody, “The experiential difference between watching a movie in a theatre and on a screen at home varies for every movie, and in no predictable way.” (newyorker.com)
- A visit to the Las Vegas Sphere can be disorienting. (slate.com)
Music
- Only 6 of the top 20 streamed songs of 2025 were released this year. (sherwood.news)
- The best albums of 2025 including ‘Lux’ by Rosalia. (variety.com)
- The best albums of 2025 including ‘Getting KIlled’ by Geese. (theatlantic.com)
TV
- The best TV shows of 2025 including ‘The Studio.’ (variety.com)
- The 10 best TV shows of 2025 including ‘The Lowdown.’ (washingtonpost.com)
- The 10 best TV shows of 2025 including ‘The Pitt.’ (slate.com)
Movies
- The best movies of 2025 including ‘Train Dreams.’ (variety.com)
- The 10 best movies of 2025 including ‘One Battle After Another.’ (slate.com)
- The best movies of 2025 including ‘Blue Moon.’ (theatlantic.com)
College
- What it’s like to perform triage on a dying liberal arts college. (bloomberg.com)
- The University of Texas has come under heel of the state. (nytimes.com)
Children
- Why do we still take school photos? (theatlantic.com)
- Schools are increasingly unlikely to assign whole books to read. (nytimes.com)
Earlier on Abnormal Returns
- What you missed in our Friday linkfest. (abnormalreturns.com)
- Podcast links: learning the wrong lessons. (abnormalreturns.com)
- Don’t miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
Mixed media
- The 10 best books of 2025 including “What We Can Know” by Ian McEwan. (theatlantic.com)
- The 10 best books of 2025 including “The Undiscovered Country: Triumph, Tragedy, and the Shaping of the American West” by Paul Andrew Hutton. (wsj.com)
- The best audiobooks of 2025 including “Careless People: A Cautionary Tale of Power, Greed, and Lost Idealism” by Sarah-Wynn Williams. (slate.com)
- The 17 Best Books of 2025 including “All Consuming: Why We Eat the Way We Eat Now” by Ruby Tandoh. (vanityfair.com)
- The 10 best books of 2025 including “Murderland: Crime and Bloodlust in the Time of Serial Killers” by Caroline Fraser. (slate.com)
Terms and Conditions
This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.
The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.
References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.
Please see disclosures here.
